manilatimes26m
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 million Reports preliminary full-year 2024 revenue in the range of approximately $73.1 million to ...
T-Mobile Director Bought Large Block of Stock
André Almeida, a Deutsche Telekom executive and T-Mobile director, bought nearly $1 million of T-Mobile shares in early ...
GGIP in Iraq: TotalEnergies Launches Construction of an Early Gas Treatment Unit to Stop Flaring and Supply Power Plants
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) (45%, operator) and its partners Basra Oil Company (30%) and QatarEnergy (25%) launched today the construction works of ArtawiGas25, a first processing ...
Green Leaf Innovations, Inc. 40 Billion Authorized Share Reduction Update
PEMBROKE PINES, FL / / January 10, 2025 / Green Leaf Innovations, Inc. (OTC PINK:GRLF), a leading distributor of premium handmade cigars, today announced the completion regarding its authorized ...
Spero Therapeutics, Inc.: Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
Esther Rajavelu Appointed Interim President and Chief Executive Officer, Frank Thomas Appointed Chairman of the Board Interim Changes to Leadership Follow the Company's Response to a Wells Notice from ...
Coinbase faces CFTC scrutiny in ongoing Polymarket investigation
The crypto betting platform is banned in the U.S. but gained increased prominence during the 2024 U.S. presidential election.
manilatimes1h
Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...
Taiwan News1h
NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
In December 2024, NextCure announced that the U.S. Food and Drug Administration had cleared its Investigational New Drug application for LNCB74. LNCB74 is being developed in partnership with LigaChem ...
Many ‘impact investors’ aren’t fully tracking whether their investments are good for society or the environment − new research
After conducting 124 interviews with impact investors and an experiment with 435 participants, we found that, rather than evaluate impact risk directly, many impact investors presume that they will ...
iTeos Announces 2025 Strategic Priorities and Anticipated Milestones
Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...
cryptonews3h
Regulation Will Make or Break Crypto Adoption in 2025—Analysts
The changing regulatory environment in both the U.S. and the EU will be crucial to increased crypto adoption in 2025, experts ...
Ramel Lee Gives Nontraditional Investors Opportunity At Generational Wealth Through RDL Hotel Fund
RD Lee Capital Partners launched the RDL Hotel Fund I on Vesterr. This gives nonaccredited investors a chance they wouldn't ...